Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2012
11/29/2012WO2012159700A1 Solid phase-bound elastase-binding assay for the measurement of alpha,-antitrypsin activity
11/29/2012WO2012159674A1 Method of screening for therapeutic compounds useful in detoxifying central nervous system from b-amyloid peptide
11/29/2012WO2012159638A1 Non-cytotoxic alpha viral construct, cell line and composition and a method for the assessment of the effect of antiviral agents.
11/29/2012WO2012159621A1 Method and arrangement for quantifying subgroups from a mixed population of cells
11/29/2012WO2012159275A1 Blood typing system
11/29/2012WO2012159264A1 Bioanalytical reagent used in heterogeneous phase and usage method thereof
11/29/2012WO2012159171A1 A system for the capture of a biological or chemical entity i
11/29/2012WO2012159170A1 A system for the capture of a biological or chemical entity ii
11/29/2012WO2012139089A3 Fungal-derived carbohydrate-conjugated scaffold
11/29/2012WO2012135714A3 Serine biosynthesis pathway inhibition for treatment of cancer
11/29/2012WO2012131403A4 Aptamer coated measurement and reference electrodes and methods using same for biomarker detection
11/29/2012WO2012129455A3 Microfluidic devices and methods of manufacture and use
11/29/2012WO2012129246A9 Method for predicting severity of allergic reaction
11/29/2012WO2012129150A3 Metal-enhanced photoluminescence from carbon nanodots
11/29/2012WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
11/29/2012WO2012125424A3 Biological sample collection device and system
11/29/2012WO2012122236A3 Method and system to detect and diagnose alzheimer's disease
11/29/2012WO2012121594A9 Methods and means for monitoring disruption of tissue homeostasis in the total body
11/29/2012WO2012120546A3 Method for monitoring anticoagulant therapy
11/29/2012WO2012118866A3 Methods to build 3d digital models of porous media using a combination of high- and low-resolution data and multi-point statistics
11/29/2012WO2012107778A3 Mutant pores
11/29/2012WO2012106396A9 Citrullinated histone h3 (cit h3) in septic shock
11/29/2012WO2012103511A3 Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
11/29/2012WO2012097276A3 Bcl-2-like protein 11 srm/mrm assay
11/29/2012WO2012092012A3 Processes and systems for characterizing and blending refinery feedstocks
11/29/2012WO2012081856A3 Method for preparing nucleic acid probe-coated porous solid support strip
11/29/2012WO2012075069A3 Signatures and determinants associated with cancer and methods of use thereof
11/29/2012WO2012075023A3 Neoantibodies for diagnosing tissue injury
11/29/2012WO2012072515A3 Lmp1 a diagnostic and prognostic marker for epstein-barr virus (ebv)-associated lymphoma
11/29/2012WO2012050876A3 Nanowires for electrophysiological applications
11/29/2012WO2012034199A3 Fuel level sensor, method for measuring fuel level by electrical conductivity and method for identifying the type of ethanol/gasoline fuel blend
11/29/2012WO2012020307A3 Therapeutic uses of microvesicles and related micrornas
11/29/2012US20120304330 Elite event ee-gm3 and methods and kits for identifying such event in biological samples
11/29/2012US20120304319 Tox3 as a biomarker for breast cancer
11/29/2012US20120304318 Cancer diagnosis and treatment
11/29/2012US20120304317 Transgenic rodent expressing truncated disc1
11/29/2012US20120303472 Methods for placing, accepting, and filling orders for products and services
11/29/2012US20120303286 System for animal health diagnosis
11/29/2012US20120303284 Determination of timing of chemotherapy delivery
11/29/2012US20120303230 Engine friction based oil viscosity monitor
11/29/2012US20120303083 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
11/29/2012US20120302940 Popcorn Shape Gold Nanoparticle For Targeted Diagnosis, Photothermal Treatment and In-Situ Monitoring Therapy Response for Cancer and Multiple Drug Resistance Bacteria
11/29/2012US20120302741 Non-invasive detection of fetal genetic traits
11/29/2012US20120302650 Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein SRM/MRM Assay
11/29/2012US20120302649 Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302624 Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
11/29/2012US20120302603 Amyloid binding agents
11/29/2012US20120302595 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
11/29/2012US20120302516 Nanoparticles for drug delivery
11/29/2012US20120302460 Use of Low Affinity Neurotrophin Receptor P75 As Marker for High Differentiation Potential Muscle Stem Cells, Muscle Satellite Cells, And Degenerative Skeletal Muscle Diseases
11/29/2012US20120302456 Vertical flow-through devices for multiplexed elisa driven by wicking
11/29/2012US20120302452 Comparative ligand mapping from mhc class i positive cells
11/29/2012US20120301974 Clozapine Immunoassay
11/29/2012US20120301973 Clozapine immunoassay
11/29/2012US20120301970 Methods and kits for quantitative determination of total organic acid content in a coolant
11/29/2012US20120301910 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
11/29/2012US20120301906 Tsh immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues
11/29/2012US20120301905 Tsh immunoassays and processes for performing tsh immunoassays in the presence of endogenous contaminants in restricted wash formats
11/29/2012US20120301904 Multiprotein assemblies
11/29/2012US20120301903 Microfluidic Devices and Methods of Manufacture and Use
11/29/2012US20120301902 Gemcitabine Immunoassay
11/29/2012US20120301901 Gemcitabine immunoassay
11/29/2012US20120301900 Apparatus and method for detecting tumor cells
11/29/2012US20120301899 Use of novel markers of pluripotent stem cells
11/29/2012US20120301898 Assessing non-alcoholic fatty liver disease
11/29/2012US20120301897 Acetaminophen-protein adduct assay device and method
11/29/2012US20120301896 Tsh antibodies for point-of-care immunoassay formats
11/29/2012US20120301895 Methods of modulating binding of son of sevenless to phosphatidic acid and identifying compounds that modulate such binding
11/29/2012US20120301893 Analyte Detection Devices, Multiplex and Tabletop Devices for Detection of Analyte, and Uses Thereof
11/29/2012US20120301891 Biomarkers of cancer metastasis
11/29/2012US20120301889 Method and reagents for identifying pluripotent stem cells
11/29/2012US20120301882 Methods for generating databases and databases for identifying polymorphic genetic markers
11/29/2012US20120301879 Novel use of ca-125
11/29/2012US20120301871 Comparative ligand mapping from mhc positive cells
11/29/2012US20120301582 Systems and Methods for Selecting Flour
11/29/2012US20120301501 Method for selecting and producing vaccine components and vaccines based thereon
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301491 Use of Modified Extracellular Matrix Proteins in Diagnosis and Treatment of Atherosclerosis
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301482 Methods and compositions for treatment of lung injury
11/29/2012US20120301477 USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
11/29/2012US20120301475 Novel heparanase splice variant
11/29/2012US20120301468 Anti-mn antibodies and methods of using same
11/29/2012US20120301467 Fas binding antibodies
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012US20120301454 Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
11/29/2012US20120301404 Treatment of cachexia
11/29/2012US20120301402 Rap1a as a marker for cardiac arrhythmia
11/29/2012US20120301398 Radiolabelled glutaminyl cyclase (qc) inhibitors and uses of same
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012US20120301393 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
11/29/2012US20120301362 System for testing a bodily fluid sample
11/29/2012US20120298528 Biosensor and analysis method using same
11/29/2012US20120297859 Film Bulk Acoustic Wave Resonator-Based Ethanol and Acetone Sensors and Methods Using the Same
11/29/2012DE112009004267T5 Rekombinantes Antigen für den Nachweis vonToxokarose The recombinant antigen for the detection vonToxokarose
11/29/2012DE10226580B4 Armbanduhr mit Meßfunktion Wristwatch with a measuring function
11/29/2012DE102012102875A1 Vorläuferauswahl mit einem Artificial-Intelligence-Algorithmus erhöht Abdeckung und Reproduzierbarkeit von proteomischen Proben Precursor selection with an Artificial Intelligence algorithm increases coverage and reproducibility of proteomic samples
1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 3937